Form 4 Filing for Scott Kathleen D.

This filing details a transaction by Scott Kathleen D., a director at Dermata Therapeutics, Inc. On June 16, 2026, Scott Kathleen D. disposed of 11 shares of Common Stock at a price of $1.1901 per share. This transaction resulted in a post-transaction ownership of 0 shares. Following this transaction, Scott Kathleen D. directly owns 1 share of Common Stock, held indirectly through the Scott 2008 Trust dated 3/28/08.